Oct. 19 at 8:41 PM
$CNSP is heating up after Orphan Drug status for its neuro-oncology lead TPI-287.
The NASDAQ small-cap in the healthcare/biotech space shows major upside potential — analysts target ~
$20 vs current ~
$9.
Are we looking at a bullish opportunity here? Read the blog for full context: https://www.acrossmarkets.icu/2025/10/small-cap-biotech-cns-pharmaceuticals.html